Greenman William Mariner

Avg. Two Year Performance

39% Avg. Purchase Return
18% Compound
3% Avg. Sale Return
2% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return14%23%25%50%39%
Purchase Success Rate4 of 43 of 42 of 44 of 43 of 4
Average Sale Return(10%)(10%)(11%)6%3%
Sale Success Rate2 of 63 of 63 of 62 of 62 of 6
Drugs » Biotechnology

President and CEO, Director:

Holdings: 1.42M shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($997.52K) Net Amount
Buy:0--
Sell:($997.52K)$6.38
Drugs » Biotechnology

Director:

Holdings: 19.84K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--